Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07210567 · ClinicalTrials.gov registry record · NA
Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
A NA study of Smoking Cessation, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07210567: Recruiting NA study of Smoking Cessation, sponsored by Rutgers, The State University of New Jersey.
NCT07210567 is a NA study of Smoking Cessation that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 50 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07210567, a NA study of Smoking Cessation, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to develop a new quit-smoking treatment among individuals with a cancer diagnosis using a smartphone app.
Primary Outcome
Perceived usability and learnability of the app will be measured on a 5-point scale (1=strongly disagree; 5=strongly agree).
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness
- BEHAVIORAL Quitline
Study Locations (1)
New Jersey
- Institute for Nicotine & Tobacco Studies - New Brunswick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-01-06 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
What NCT07210567 shows while recruiting
NCT07210567 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness is the first listed.
NCT07210567 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07210567 about?
NCT07210567 is a clinical study titled "Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors". The purpose of the study is to develop a new quit-smoking treatment among individuals with a cancer diagnosis using a smartphone app.
What is the current status of trial NCT07210567?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-01-06. Estimated completion is 2028-12-31.
What conditions does trial NCT07210567 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT07210567?
The interventions under investigation include: Mindfulness (BEHAVIORAL), Quitline (BEHAVIORAL).
Who is sponsoring clinical trial NCT07210567?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07210567 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07210567's enrollment target sits among peer trials
50 145th of 188 higher than 38 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI